Aeterna Zentaris Inc. (TSE:AEZS) has released an update.
Aeterna Zentaris Inc. is set to merge with Ceapro Inc. as they have received final court approval for an all-stock merger, expected to be completed in the second quarter of 2024. The merger aims to combine the strengths of Aeterna’s biopharmaceutical development and Ceapro’s plant extraction technology to address unmet medical needs. This strategic move is anticipated to enhance their offerings in pharmaceutical and diagnostic products.
For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.
